Table 2.
Niraparib | Olaparib | |||
---|---|---|---|---|
m±SD (CV%) [Udrug/(pmol/mm2)]* |
q±SD (CV%) [Udrug)]* |
m±SD (CV%) [Udrug/(pmol/mm2)]* |
q±SD (CV%) [Udrug)]* |
|
Rep 1 | 0.296±0.035 (11.8) | 0.101±0.016 (15.9) | 0.093±0.014 (14.7) | 0.0527±0.0014 (2.7) |
Rep 2 | 0.312±0.022 (7.1) | 0.104±0.009 (8.5) | 0.121±0.012 (9.7) | 0.0529±0.0012 (2.3) |
Rep 3 | 0.268±0.018 (6.8) | 0.104±0.008 (8.1) | 0.147±0.014 (9.4) | 0.0528±0.0012 (2.2) |
MEAN | 0.292 | 0.103 | 0.120 | 0.0528 |
SD | 0.022 | 0.002 | 0.027 | 0.0001 |
CV% | 7.6 | 1.7 | 22.3 | 0.2 |
* Udrug : unit of the normalised drug signal (dimensionless)